COPENHAGEN, Denmark – May 6, 2026 - Bavarian Nordic A/S (OMX: BAVA) will announce its 2026 first quarter results on Wednesday, May 13, 2026.
The management of Bavarian Nordic will host a conference call a t 2:00 pm CEST (8:00 am EDT) on the same day to present the interim results followed by a Q&A session. A listen-only version of the call and presentation slides can be accessed here. To join the Q&A session, please register in advance here.
Contacts
Europe: Disa Tuominen, IR Manager, detu@bavarian-nordic.com
US: Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com.